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Endothelin receptor antagonistsThe Twelfth International Conference on Endothelin (ET-12) was held at Clare College, University of Cambridge,
United Kingdom, from September 11–14, 2011, with researchers from basic and clinical science from nearly
20 countries attending. The conference featured a number of invited lectures, presentation of new research
in several oral and poster sessions. It also featured newly introduced and well‐received interactive panel discus-
sion reviewing results and challenges of clinical trials using endothelin receptor antagonists conducted in the
past 20 years. Evidence for new roles of endothelin in physiology and disease was presented, as well as new
data from clinical trials in cancer and renal disease suggesting therapeutic efﬁcacy of pharmacological modula-
tion of the endothelin system.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.The International Conferences on Endothelinwere established in the
late 1980s (Proceedings, 1989) after the sequences encoding for the
endothelin gene and peptide had been published in Nature on March
31, 1988 (Yanagisawa et al., 1988). Sir John Vane as the Conference
Chair organized the ﬁrst meeting as The First William Harvey Work-
shop on Endothelin in December 1988 (Proceedings, 1989) at The
WilliamHarvey Research Institute, St. Bartholomew's Hospital Medical
College, London (Fig. 1). The biennial conference has subsequently
alternated between cities in three continents, including Bergamo,
Edinburgh, Houston, Kyoto, London, Montréal, Park City, and Tsukuba.
The Twelfth International Conference on Endothelin (ET-12), chaired
by Matthias Barton (University of Zürich, Switzerland) and Anthony
Davenport (University of Cambridge, UK), took place in 2011 at Clare
College of the University of Cambridge. Over 4 days, delegates from
nearly twenty nations from around the world (Fig. 2) participated in
the scientiﬁc sessions. The conference opened on Sunday, September
11, 2011 at the Riley Auditorium of The Gillespie Centre with the
Key Note Lecture by Paul M. Vanhoutte (Hong Kong) on “The history
of endothelium-dependent contraction”, summarizing more than
30 years of endothelial cell research he was involved in (Barton,
2011). Over the four-day conference, invited lectures were given bycine, University of Zürich, LTK
erland. Tel.: +41 77 439 5554;
-NC-ND license.international experts in basic and clinical science, including Lewis
J. Rubin (San Diego), John Pernow (Stockholm), David M. Pollock
(Augusta), Donald E. Kohan (Salt Lake City), John G. Cleland (Hull),
Dan Theodorescu (Denver), Brian D. Cain (Gainesville), David J. Webb
(Edinburgh) and Masashi Yanagisawa (Dallas/Tsukuba), as well as pre-
sentations by the contributing conference speakers. A new feature
implemented by the Guest Editor was an interactive panel discussion
led Donald E. Kohan, between experts involved in the clinical develop-
ment of endothelin antagonists, which stimulated lively audience par-
ticipation and has been summarized in an article published in this
issue of the Proceedings (Kohan et al., 2012); a video recording of this
panel discussion is also available online (Kohan et al., 2012). Dennis
Andress (Abbott Laboratories), Martine Clozel (Actelion Ltd.), Hunter
Gillies (Gilead Sciences) and Neil Davie (Pﬁzer, now Bayer Healthcare)
presented updates on clinical drug development and clinical trials using
these companies' endothelin receptor antagonists. In keeping with tra-
dition, Masashi Yanagisawa (Dallas/Tsukuba) concluded the meet-
ing by delivering the special lecture summarizing the highlights of
ET-12 and speculating on the question “quo vadis, endothelin?”.
The conference program featured a number of excellent contribu-
tions delivered as oral presentations by young investigators (Fig. 3),
as well as three poster sessions, each chaired by international experts.
Sessions were held at the Gilliespie Centre, which promoted interac-
tion between senior investigators and young investigators to present
and discuss their data. The social program, organized by the ET-12
Conference Secretariat led by Karen Schlaegel, was well received
and included punting along the river Cam (Fig. 4), to view the medi-
eval colleges, and a young investigator's event sponsored by the BPS
Young Pharmacologists Committee. A highlight was the reception in
Fig. 1. Attendees and Faculty of The First William Harvey Workshop on Endothelin (ET-1) held in 1988 at the William Harvey Research Institute, St. Bartholomew's Hospital Medical
College, London, United Kingdom. The picture was taken on December 6, 1988, shown in the middle of the front row are Tomoh Masaki, Sir John R. Vane (Chair), and Paul M.
Vanhoutte (photograph courtesy of Michael Dashwood, London).
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Great Hall of Clare College's Old Court (Fig. 5). At the Gala Dinner, a
clearly delighted Masashi Yanagisawa, who as a graduate student in
1987 proposed to Professor Masaki to identify the structure of the
endothelin peptide (Yanagisawa et al., 1988), was awarded the inau-
gural Tomoh Masaki Award, for his contribution to the ﬁeld (Barton et
al., 2012). Also, in the tradition of the conference 35 early career sci-
entists received ET-13 Young Investigator Awards in recognition of
the scientiﬁc excellence of their work, as well as the newly created
ET-12 Best Presentation Awards sponsored by Elsevier for best oral
and best poster presentations delivered at the meeting by a young
investigator (Barton and Pollock, 2012).
This conference would not have been possible without the help and
support of numerous individuals and organizations including members
of the ET-12 Local Organizing Committee and the ET-12 International
Scientiﬁc Advisory Committee. On behalf of the Endothelin InternationalFig. 2. Attendees and Faculty of The Twelfth International Conference on Endothelin, Clare Colle
the front row are Chair Anthony Davenport, Honorary Chairs Paul M. Vanhoutte andMasashi
and Noriaki Emoto (photograph by Suzete Sandin).Advisory Boardwe particularly thank the main institutional sponsor, the
British Pharmacological Society (BPS) – particularly Karen Schlaegel,
Head of Meetings of BPS who headed the ET-12 Conference Secretariat,
for an outstanding job in the organization and realization of many ideas
(some of which at the very last minute) and tremendous ﬂexibility in
providing solutions – and the American Physiological Society (APS). We
also thank the conference's industrial sponsors (ET-12 Sponsors) for
providing unrestricted educational grants to support the conference,
also allowing to realize recordings of the scientiﬁc sessions which are
featured as part of the online articles of the Endothelin XII Proceedings
(Proceedings, 2012) and are also available online in HD (ET-12
Videos). Suzete Sandin (Sherbrooke) was the ofﬁcial conference pho-
tographer and took the ﬁrst group photograph of endothelin conference
delegates (Fig. 2) since the inaugural ET-1 meeting in London in 1988
(Fig. 1). We also thank Irene Kanter-Schlifke, the publisher of Life Sci-
ences, Elsevier, for supporting and sponsoring the idea of the “ET-12ge of the University of Cambridge, United Kingdom, on September 12, 2011. Standing in
Yanagisawa, and Chair Matthias Barton, as well as ET-13 Chairs-Elect, Takashi Miyauchi
Fig. 3. ET-12 scientiﬁc sessions at the Riley Auditorium, The Gillespie Centre, Clare College, The University of Cambridge (photograph by Suzete Sandin).
464 M. Barton, A.P. Davenport / Life Sciences 91 (2012) 462–465Best Presentation Awards” which includes an invitation extended to the
awardees to submit a manuscript for publication (von Brandenstein
et al., 2012) and for making it possible to realize for the ﬁrst time to
publish the conference proceedings in Life Sciences and Open Access
(Proceedings, 2012).We are particularly grateful for all abstract reviewers
and the chairs of the scientiﬁc sessionswhowere essential inmaintaining
the high scientiﬁc quality of the conference program. A permanent record
of abstracts of the ET-12 conference presentations has been created with
pA2 Online (ET-12 Abstracts).We thank Clare and St. Catharine's Colleges
of the University of Cambridge for making it possible to have themeeting
at this unique location. Finally, we thank all speakers, presenters, session
chairs, and supporters for their contribution.
Delegates departed with new ideas and enthusiasm for the next
International Conference on Endothelin (ET-13) to be held a year
from now in Tokyo, Japan (September 8–11, 2013), and that will beFig. 4. Clare College, Old Court, The University of Cambridge,chaired by Takashi Miyauchi of Tsukuba University and Noriaki
Emoto of Kobe University (ET-13 Tokyo). We are convinced that
our Japanese colleagues – who will be celebrating the 25th anniver-
sary both of the discovery of endothelin as well as of the International
Conferences on Endothelin – will create a scientiﬁcally most stimulating
conference in one of the largest cities of the world and we sincerely
wish them all success and look forward to exciting new endothelin sci-
ence to be presented in September 2013.
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Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
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